2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

By R. Bast, P. Ravdin, D. Hayes, Susan Bates, H. Fritsche, J. Jessup, N. Kemeny, G. Locker, R. Mennel, M. Somerfield. Journal of Clinical Oncology, 2001

846 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/f9a20c385e5b1ca3dc377de2dba45a28fae5ba2e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Douglas G. Altman

In Oncology

1. Douglas G. Altman
2. Gary S. Collins
3. Karel G. M. Moons
4. Johannes B Reitsma
5. I. Slaninová

Citations in the corpus

• REporting recommendations for tumour MARKer prognostic studies (REMARK) (2005, background): “…UK Keywords: tumour marker; guidelines; REMARK; NCI; EORTC; prognostic Despite years of research and hundreds of reports on tumour markers in oncology, the number of markers that have emerged as clinically useful is pitifully small (Hayes et al, 1996; Bast et al, 2001; Schilsky and Taube, 2002).”